Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

News
CCBIO gruppebilde

CCBIO's 7th Annual Symposium (2019)

World leading cancer experts met at Solstrand: International top notch cancer researchers met at Solstrand to present their work at CCBIO's annual symposium.

faculty award
Elisabeth receiving the award from the dean.

Faculty Internationalization Award to Elisabeth Wik

Congratulations to CCBIO's Elisabeth Wik for a very well deserved Faculty Internationalization Award! The prize was presented at the Faculty Day, June 13th 2019.

Conference
Gruppebildet av konferansedeltakerne

International fibrosis conference in Bergen

On May 23 and 24, 2019, the world's leading fibrosis and cancer researchers met in Bergen at an international fibrosis conference on the topic "New tools to study the fibrotic stroma".

next generation immunohistochemistry
Scenes from the symposium. Lecturer and audience.

"Google map" for tumors

The University of Bergen has just implemented the Hyperion Imaging System, next generation immunohistochemistry where researchers can explore tissue biology with 35 antibodies simultaneously. This instrument is the only of its kind in Northern Europe, and is open for booking for all researchers on...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.